接受利妥昔单抗-CHOEP-14方案治疗的B细胞淋巴瘤患者中的耶氏肺孢子菌肺炎
Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.
作者信息
Kolstad Arne, Holte Harald, Fosså Alexander, Lauritzsen Grete Fossum, Gaustad Peter, Torfoss Dag
出版信息
Haematologica. 2007 Jan;92(1):139-40. doi: 10.3324/haematol.10564.
PMID:17229653
Abstract
We report six cases of Pneumocystis jirovecii pneumonia (PCP) verified by immunoflourescence/polymerase chain reaction of bronchoalveolar fluid among 46 lymphoma patients (13%) who received rituximab-CHOEP-14 at our institution. PCP prophylaxis should be standard management for this group of patients and also considered for patients treated with rituximab-CHOP-14, CHOP-14 or CHOEP-14.
摘要
我们报告了在我院接受利妥昔单抗-CHOEP-14方案治疗的46例淋巴瘤患者（占13%）中，通过支气管肺泡灌洗液免疫荧光/聚合酶链反应确诊的6例耶氏肺孢子菌肺炎（PCP）病例。对于这组患者，PCP预防应作为标准治疗措施，对于接受利妥昔单抗-CHOP-14、CHOP-14或CHOEP-14方案治疗的患者也应考虑进行PCP预防。
Zotero 插件